BRIEF published on 04/10/2024 at 14:35, 2 years ago PharmaCord Appoints Cindy Padgett as Chief Commercial Officer Chief Commercial Officer Healthcare Industry PharmaCord Cindy Padgett Patient Support Services
BRIEF published on 04/10/2024 at 14:35, 2 years ago PharmaCord nomme Cindy Padgett au poste de directrice commerciale PharmaCord L'industrie De La Santé Directeur Commercial Cindy Padgett Services De Soutien Aux Patients
BRIEF published on 04/10/2024 at 14:20, 2 years ago Hannan Metals Ltd. Discovers New Gold-Copper Porphyry Target in Peru Mineral Exploration Valiente Project Peru Mining Hannan Metals Ltd Gold-Copper Porphyry
BRIEF published on 04/10/2024 at 14:20, 2 years ago Hannan Metals Ltd. découvre une nouvelle cible de porphyre or-cuivre au Pérou Exploration Minérale Exploitation Minière Au Pérou Hannan Metals Ltée Porphyre Or-Cuivre Projet Valiente
BRIEF published on 04/10/2024 at 14:13, 2 years ago North Peak Resources Advances Drilling Program at Prospect Mountain to Target Gold Prospect Mountain North Peak Resources Eureka, Nevada Gold Drilling Kenogami Lake Project
BRIEF published on 04/10/2024 at 14:13, 2 years ago North Peak Resources fait progresser son programme de forage à Prospect Mountain pour cibler l'or Eureka, Nevada Forage D'or Ressources Du Pic Nord Montagne Des Perspectives Projet Du Lac Kénogami
BRIEF published on 04/10/2024 at 14:11, 2 years ago TUI AG Announces Major Shareholding Notifications Under German Securities Trading Act Société Générale TUI AG German Securities Trading Act Shareholding Financial Instruments
BRIEF published on 04/10/2024 at 14:11, 2 years ago TUI AG annonce d'importantes notifications d'actionnariat en vertu de la loi allemande sur le commerce des valeurs mobilières Société Générale TUI AG Actionnariat Instruments Financiers Loi Allemande Sur Le Commerce Des Valeurs Mobilières
BRIEF published on 04/10/2024 at 14:05, 2 years ago AdrenoMed Receives FDA Fast Track Designation for Enibarcimab in Septic Shock Treatment Precision Medicine AdrenoMed Enibarcimab FDA Fast Track Designation Septic Shock Treatment
BRIEF published on 04/10/2024 at 14:05, 2 years ago AdrenoMed reçoit la désignation Fast Track de la FDA pour l'énibrarcimab dans le traitement du choc septique Médecine De Précision AdrenoMed Enibarcimab Désignation Fast Track De La FDA Traitement De Choc Septique
Published on 04/22/2026 at 13:30, 1 hour 9 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:30, 1 hour 9 minutes ago Copper Road Announces Engagement of George Mannard
Published on 04/22/2026 at 13:00, 1 hour 39 minutes ago AmeriTrust Announces 2025 Annual Financial Results
Published on 04/22/2026 at 13:00, 1 hour 39 minutes ago Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji
Published on 04/22/2026 at 13:55, 44 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Consolidated Financial Statements, Dividend Proposal and Guidance
Published on 04/22/2026 at 13:55, 44 minutes ago Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone
Published on 04/22/2026 at 13:40, 58 minutes ago EQS-Adhoc: Rejection of appeal against the revocation of the admission of ZhongDe Waste Technology AG shares to trading on the regulated market (General Standard)
Published on 04/22/2026 at 13:35, 1 hour 4 minutes ago DeFi Technologies' Asset Management Business, Valour, Secures US$11 Million in Institutional Investment into Hedera ETPs, Including US$10 Million on Börse Frankfurt and US$1 Million on Sweden's Spotlight
Published on 04/22/2026 at 13:05, 1 hour 34 minutes ago EQS-Adhoc: ad pepper media International N.V.: Strongest first quarter in over 25 years of company history, EBITDA between EUR 6.5 and EUR 7.5 million expected for 2026
Published on 04/22/2026 at 07:00, 7 hours 39 minutes ago Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 7 hours 39 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 19 hours 24 minutes ago AXA - Description of the Company’s share repurchase program
